BioSpace News Archive

Atrion Corporation announced its results for the first quarter ended March 31, 2023.

Progyny, Inc. (Nasdaq: PGNY) (“Progyny” or the “Company”) today announced its financial results for the three-month period ended March 31, 2023 (“the first quarter of 2023”) as compared to the three-month period ended March 31, 2022 (“the first quarter of 2022” or “the prior year period”).

Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC) today announced that its first quarter 2023 financial results will be released on Monday, May 15, 2023 before the U.S. financial markets open.

Coherus BioSciences, Inc. (“Coherus”, “the Company”, Nasdaq: CHRS), today reported financial results for the quarter ended March 31, 2023 and recent business highlights.

Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today reported its financial results for the quarter ended March 31, 2023 and provided a business update.

Cullgen Inc., a leading biotechnology company developing small molecule therapeutics based on its proprietary uSMITE™ platform of targeted protein degradation technology, announced that it has raised $40 million in new financing.

Atara Biotherapeutics, Inc. (Nasdaq: ATRA) today reported financial results for the first quarter 2023, recent business highlights and key upcoming catalysts.

INVO Bioscience, Inc. (NASDAQ: INVO) will report financial results for its first quarter 2023, for the period ended March 31, 2023, after the market close on Monday, May 15, 2023.

Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that Nature Biotechnology has published a paper titled “Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques.”

Cytokinetics, Incorporated announced that Robert I. Blum, President and Chief Executive Officer, is scheduled to participate in a fireside chat at the JMP Securities Life Sciences Conference on Monday, May 15, 2023 at 9:00 AM Eastern Time at the New York Hilton Midtown in New York, NY.